Title

COVID-19 Guideline Part 4: Serologic Testing

Authoring Organization

Infectious Diseases Society of America

Publication Month/Year

February 9, 2024

Last Updated Month/Year

February 10, 2024

Supplemental Implementation Tools

Document Type

Guideline

Country of Publication

US

Document Objectives

IDSA’s goal was to develop evidence-based recommendations that assist clinicians, clinical laboratories, patients and policymakers in decisions related to the optimal use of SARS-CoV-2 serologic tests in a variety of settings. We also highlight important unmet research needs pertaining to the use of anti-SARS-CoV-2 antibody tests for diagnosis, public health surveillance, vaccine development and the selection of convalescent plasma donors.

Inclusion Criteria

Male, Female, Adolescent, Adult, Child, Older adult

Health Care Settings

Ambulatory, Hospital, Laboratory services

Intended Users

Epidemiology infection prevention, laboratory technician, nurse, nurse practitioner, physician, physician assistant

Scope

Diagnosis, Assessment and screening

Diseases/Conditions (MeSH)

D000086382 - COVID-19, D000087124 - COVID-19 Serological Testing

Keywords

covid-19, serologic testing, COVID, serological testing

Source Citation

Mary K. Hayden, Ibrahim K. El Mikati, Kimberly E. Hanson, Janet A. Englund, Romney M. Humphries, Francesca Lee, Mark Loeb, Daniel J. Morgan, Robin Patel, Omar Al Ta’ani, Jamil Nazzal, Shahad Iqneibi, Justin Z. Amarin, Shahnaz Sultan, Yngve Falck-Ytter, Rebecca L. Morgan, M. Hassan Murad, Adarsh Bhimraj, Reem A. Mustafa. Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Serologic Testing. Infectious Diseases Society of America 2024; Version 2.0. Available at https://www.idsociety.org/practice-guideline/covid-19-guideline-serology/